Stocks in play: NorZinc Ltd.
Announced that its Securityholders (as defined below) have approved the proposed plan of arrangement under Division 5 of Part 9 of the Business Corporations Act (British Columbia) whereby RCF VI CAD LLC will acquire all of the issued and outstanding common shares of the Company that RCF and its affiliates do not currently own for $0.0325 in cash per NorZinc share at a special meeting of Securityholders held yesterday, December 5. NorZinc Ltd. shares T.NZC are trading unchanged at $0.03.
Read:
Latest Set of FDA Fast Track Designations Causing Optimism in Biotech Sector
Biotech Sector to Unveil New Data and Developments at 2022 SABCS in San Antonio
Biotech Sector Witnessing Growing Revenue Potential in Ongoing Battle Against Pancreatic Cancer
New Biotech Sector Drug Combinations Target a Drop in Pancreatic Cancer Mortality Rates
Highly Sought After Natural Ingredients Appearing in More Plant-Based Products Across North America